• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Eslicarbazepine acetate (Zebinix®) 800 mg tablets
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ramipril 2.5 mg/5 ml oral solution
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Mercaptopurine (Xaluprine®) 20 mg/ml oral suspension
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Trastuzumab (Herceptin®) 150 mg powder for concentrate for solution for infusion
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sitagliptin (Januvia®) 25 and 50 mg tablets
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Vildagliptin (Galvus®) 50 mg tablets
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rufinamide (Inovelon®) 40 mg/ml oral suspension
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical guides in antibiotic treatment, 2nd series]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Diagnosis and treatment of chronic cerebrospinal venous insufficiency (CCSVI) for people with multiple sclerosis]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Budget impact analysis of increasing kidney transplantation in Québec]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Implantable ventricular assist devices: assessment of evidence and required elements to establish a clinical registry in Québec]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Low-intensity ultrasound for the treatment of fractures]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Promising measures to reduce the use of a avoidable obstetrical interventions with low-risk women]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Sentinel lymph node biopsy in breast cancer treatment: efficacy and safety]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Transcatheter aortic valve implantation: Evaluation of the evidence and synthesis of organizational issues]
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Use of intrathecal pumps in chronic pain management: efficacy, safety, clinical indications and organizational methods]
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) Drotrecogin alfa (Activated) in severe sepsis: a systematic review of observational studies (Update of Report 29)
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) Video capsule endoscopy for obscure GI bleeding and Crohn's disease (Update of Report 7)
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) 532 nm KTP laser for vocal fold surgery
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of serum procalcitonin levels in treatment decisions for adult patients in the intensive care unit
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) The impact of reports of The Technology Assessment Unit of the McGill University Health Centre
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) Hyaluronic acid fat graft myringoplasty or Epidisk Tympanoplasty (ET)
2012 Agency for Healthcare Research and Quality (AHRQ) Screening and diagnosing gestational diabetes mellitus
2012 Agency for Healthcare Research and Quality (AHRQ) Multigene panels in prostate cancer risk assessment
2012 Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - The patient-centered medical home
2012 Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Quality improvement interventions to address health disparities
2012 Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Bundled payment: effects on health care spending and quality
2012 Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Public reporting as a quality improvement strategy
2012 Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Medication adherence interventions: comparative effectiveness
2012 Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Quality improvement measurement of outcomes for people with disabilities
2012 Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Improving health care and palliative care for advanced and serious illness
2012 Agency for Healthcare Research and Quality (AHRQ) Allocation of scarce resources during mass casualty events
2012 Agency for Healthcare Research and Quality (AHRQ) Diagnosis and management of febrile infants (0–3 months)
2012 Agency for Healthcare Research and Quality (AHRQ) An evidence review of active surveillance in men with localized prostate cancer
2012 Agency for Healthcare Research and Quality (AHRQ) Enabling health care decisionmaking through clinical decision support and knowledge management
2012 Agency for Healthcare Research and Quality (AHRQ) Closing the quality gap: revisiting the state of the science series - Prevention of healthcare associated infections
2012 NIHR Health Technology Assessment programme Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development
2012 NIHR Horizon Scanning Centre (NIHR HSC) Dacomitinib for advanced or metastatic non-small cell lung cancer – second or third line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Dovitinib for metastatic renal cell carcinoma
2012 NIHR Horizon Scanning Centre (NIHR HSC) Enobosarm (Ostarine) for cachexia in patients with advanced non-small cell lung cancer – first line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Enzastaurin for diffuse large B-cell lymphoma – following complete remission
2012 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) for advanced, unresectable or metastatic neuroendocrine tumours
2012 NIHR Horizon Scanning Centre (NIHR HSC) Nanoliposomal irinotecan for metastatic pancreatic cancer in patients who have progressed on prior gemcitabine-based therapy
2012 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for maintenance treatment in relapsed chronic lymphocytic leukaemia (CLL) patients responding to induction therapy
2012 NIHR Horizon Scanning Centre (NIHR HSC) Pomalidomide for multiple myeloma – third line
2012 NIHR Horizon Scanning Centre (NIHR HSC) Velimogene aliplasmid (Allovectin) for advanced or metastatic malignant melanoma
2012 NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) monotherapy for advanced breast cancer
2012 NIHR Horizon Scanning Centre (NIHR HSC) Cangrelor to reduce platelet aggregation and thrombosis in patients undergoing percutaneous coronary intervention
2012 NIHR Horizon Scanning Centre (NIHR HSC) SAR236553/REGN727 for the reduction of elevated total cholesterol and low density lipoprotein cholesterol
2012 NIHR Horizon Scanning Centre (NIHR HSC) Spartan RX™ point-of-care DNA test for identifying the CYP2C19*2 mutation
2012 NIHR Horizon Scanning Centre (NIHR HSC) Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO®) impulse system for acute coronary syndromes including heart attack
2012 NIHR Horizon Scanning Centre (NIHR HSC) SCOUT DS® and Diab-spot for type 2 diabetes screening
2012 NIHR Horizon Scanning Centre (NIHR HSC) Faldaprevir with BI 207127 for chronic hepatitis C infection, genotype 1
2012 NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for active and progressive psoriatic arthritis
2012 NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for ankylosing spondylitis – second line
2012 NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Alair® bronchial thermoplasty system for severe asthma
2012 NIHR Horizon Scanning Centre (NIHR HSC) Tofacitinib for moderate to severe chronic plaque psoriasis – second line
2012 NIHR Horizon Scanning Centre (NIHR HSC) ICX-RHY (Vavelta) for recessive dystrophic epidermolysis bullosa –second line
2012 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Impact of day care centres in monitoring patients with Obstructive Sleep Apnea Syndrome (OSAS)]
2012 Health Information and Quality Authority (HIQA) Health technology assessment of a national deep brain stimulation service in Ireland
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [HIV screening in the general population]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening for colorectal cancer part 1: screening-tests and program design
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Lenalidomide (Revlimid®) for the first-line therapy of transplant-ineligible patients with multiple myeloma
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Evidence overview of therapeutic hypothermia]
2012 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Researchers' perceptions about the clinical and health services research call]
2012 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Catalan arthroplasty register. 2nd report (data 2005-2010)]
2012 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Pharmacological treatment for controlled ovarian hyperstimulation in vitro fertilization]
2012 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Non-traumatic neck pain: appropriateness use of diagnostic imaging tests]
2012 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Idebenone for the treatment of Friedreich's ataxia]
2012 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Priorization for patients on waiting lists: development of a generic system]
2012 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Digital hearing aid in comparison with analog hearing aid for presbycusis: evaluation of the clinical effectiveness and the cost-effectiveness]
2012 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline of care for people with multiple sclerosis]
2012 Andalusian Health Technology Assessment Area (AETSA) [Safety and effectiveness of oncolytic viruses in advanced cancer. systematic review of the literature]
2012 Andalusian Health Technology Assessment Area (AETSA) [Extended neonatal screening for lysosomal diseases by mass spectrometry]
2012 Andalusian Health Technology Assessment Area (AETSA) [New oral anticoagulants for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation]
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin detemir (Levemir®) 100 U/ml solution for injection
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fidaxomicin (Dificlir®) 200 mg film-coated tablets
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Degarelix (Firmagon®) 80 mg and 120 mg subcutaneous injection
2012 Agency for Healthcare Research and Quality (AHRQ) Measuring health-related quality of life for patients with diabetic retinopathy
2012 Agency for Healthcare Research and Quality (AHRQ) Systematic review of ECG-based signal analysis technologies for evaluating patients with acute coronary syndrome
2012 Agency for Healthcare Research and Quality (AHRQ) Update on mapping the landscape of genetic tests for non-cancer diseases/conditions
2012 Adelaide Health Technology Assessment (AHTA) Television marketing of unhealthy food and beverages to children in Australia: a review of published evidence from 2009
2012 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Bypass surgery performed with or without the use of heart-lung machine]
2012 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Rotavirus vaccination - a health technology assessment]
2012 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [High dose brachytherapy for head and neck carcinomas]
2012 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Neuroreflexotherapy in the treatment of nonspecific low back pain]
2012 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Role of PET/CT with choline analogue radiotracers in the diagnosis and staging of prostate cancer]
2012 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Transcatheter closure paravalvular leaks with Amplatzer]
2012 Andalusian Health Technology Assessment Area (AETSA) [Rapid tests for methicillin resistant Staphylococcus aureus. Carrier screening. Executive summary]
2012 Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticularcourse juvenile idiopathic arthritis - a systematic review update
2012 HAYES, Inc. Afirma® thyroid FNA analysis
2012 HAYES, Inc. Anaplastic lymphoma kinase (ALK) gene rearrangement testing in non-small cell lung cancer (NSCLC)
2012 HAYES, Inc. Fibrinogen-beta (FGB) c.-455G>A polymorphism testing in cardiovascular disease
2012 HAYES, Inc. Harmony™ Prenatal Test
2012 HAYES, Inc. Mammostrat® for prognosis of breast cancer recurrence
2012 HAYES, Inc. Multiple endocrine neoplasia type 2 (MEN2)
2012 HAYES, Inc. Thyroid hormone receptor beta (THRB) gene testing in resistance to thyroid hormone (RTH)
2012 The Regional Health Technology Assessment Centre (HTA-centrum) [Medication reviews for patients in nursing homes. Part I: Effects on mortality and hospitalizations]
2012 The Regional Health Technology Assessment Centre (HTA-centrum) Diagnostic agreement of digital whole slide imaging and routine light microscopy
2012 The Regional Health Technology Assessment Centre (HTA-centrum) Vitamin D supplementation in patients with active or latent tuberculosis